COMMUNIQUÉS West-GlobeNewswire

Devenez membre PREMIUM

Accèdez sans limite aux 15 000 actualités du site
et recevez gratuitement chaque semaine,
la Newsletter Santé log avec les actus Santé à ne pas manquer !

S'abonner
29€ TTC/an

Je suis déjà membre PREMIUM

Se connecter

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Launches April Promotion Offering 42.0% Off Medical Cannabis Evaluations
04/04/2025 - 10:20
MESQUITE, NV, April 04, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV — Dogecoin Cash, Inc. (OTCIQ: CBDS), is pleased to announce that its subsidiary, PrestoDoctor ( www.prestodoctor.com ), is rolling out a limited-time April [...]
New LabTAG Add-On Streamlines Laboratory Labeling with Dymo® LabelWriter™ 5-Series and eLabNext Integration
04/04/2025 - 11:48
BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- GA International , a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its DYMO® LabelWriter™ 5-Series Printing Kits are now [...]
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025
04/04/2025 - 07:00
Oslo, April 04, 2025, the Board of Directors hereby calls for the Annual General Meeting of Zelluna ASA at 14:00 CET on April 29, 2025. The General Meeting will be held electronically. For participation, please log in [...]
IBA présente sa stratégie de croissance à long terme lors de son Capital Markets Day 2025
04/04/2025 - 07:00
Louvain-la-Neuve, Belgique, le 4 avril 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules, organise un Capital Markets Day (CMD-journée investisseurs) ce [...]
IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day
04/04/2025 - 07:00
Louvain-la-Neuve, Belgium, 04 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from [...]
Anne Whitaker Appointed as Non-Executive Director
04/04/2025 - 00:13
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as a Non-Executive [...]
Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
04/04/2025 - 00:18
Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time Points Educational [...]
Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs
04/04/2025 - 00:58
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2025 - 22:00
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
I-Mab Reports Full Year 2024 Financial Results and Provides Business Update
03/04/2025 - 22:01
Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025 Enrollment completed ahead of schedule in the first [...]
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/04/2025 - 22:01
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
03/04/2025 - 22:03
VALENCIA, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the U.S. commercial [...]
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
03/04/2025 - 22:05
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million upfront payment and expand dataset to combination therapy New interim data [...]
Vaxil: Management and Operational Update
03/04/2025 - 22:05
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), is pleased to make the following updates [...]
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
03/04/2025 - 22:05
EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for [...]
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
03/04/2025 - 22:05
-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital Equipment, Raising [...]
Theratechnologies annoncera ses résultats financiers du premier trimestre de l’exercice financier de 2025 et fera une mise à jour de ses activités
03/04/2025 - 22:30
MONTRÉAL, 03 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui que la [...]
Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
03/04/2025 - 22:30
MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report [...]
Praxis Precision Medicines to Participate in Upcoming April Conferences
03/04/2025 - 23:00
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]

Pages